Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-39,200
Closed -$4.68M 6403
2025
Q1
$4.68M Buy
+39,200
New +$4.86M ﹤0.01% 2930
2024
Q4
Sell
-2,600
Closed -$351K 6537
2024
Q3
$351K Sell
2,600
-8,900
-77% -$1.19M ﹤0.01% 5102
2024
Q2
$1.56M Buy
11,500
+9,200
+400% +$1.25M ﹤0.01% 3752
2024
Q1
$297K Buy
+2,300
New +$278K ﹤0.01% 5148
2023
Q2
Sell
-23,800
Closed -$2.49M 6770
2023
Q1
$2.49M Sell
23,800
-2,400
-9% -$251K ﹤0.01% 3224
2022
Q4
$2.9M Buy
26,200
+23,600
+908% +$2.47M ﹤0.01% 3243
2022
Q3
$227K Buy
+2,600
New +$236K ﹤0.01% 5568
2019
Q2
Sell
-10,000
Closed -$790K 4530
2019
Q1
$790K Hold
10,000
﹤0.01% 3007
2018
Q4
$667K Buy
+10,000
New +$692K ﹤0.01% 2797

Other funds holding XYL

Israel Englander's XYL Position: Q2 2026 in Review

Israel Englander reduced its Xylem (XYL) stake by 4.6% in Q2 2026, selling an estimated $1.83M and leaving 331,004 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #1054.

Israel Englander first reported a position in XYL in Q2 2013 and has held it in 50 quarters since. The position peaked at $216M in Q2 2023. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Israel Englander held 331,004 shares of Xylem worth $39.1M as of Q2 2026.
  • Israel Englander sold 15,861 Xylem shares in Q2 2026, an estimated $1.83M.
  • Xylem made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1054 holding.
  • Israel Englander first reported a position in Xylem in Q2 2013 and has held it in 50 quarters since.
  • Israel Englander's Xylem position peaked at $216M in Q2 2023.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.